Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,100	265	139	73	72	55
Market Cap Growth	968.52%	90.16%	91.00%	1.24%	31.51%	248.45%
Enterprise Value	1,086	263	114	47	68	32
Last Close Price	62.45	26.61	17.19	9.00	8.89	6.76
PE Ratio	52.11	313.26	1337.29	-	-	-
PS Ratio	0.86	0.86	3.07	3.80	0.81	0.57
PB Ratio	4.30	1.51	1.89	1.01	0.94	0.74
P/TBV Ratio	4.42	1.51	1.89	1.01	0.97	0.80
P/FCF Ratio	-	-	-	-	-	3.50
P/OCF Ratio	-	-	-	-	4.54	3.44
EV/Sales Ratio	0.85	0.86	2.52	2.46	0.76	0.34
EV/EBITDA Ratio	44.80	160.02	149.01	-	-	-
EV/EBIT Ratio	45.51	208.07	297.10	-	-	-
EV/FCF Ratio	-	-	-	-	-	2.07
Debt / Equity Ratio	-	-	-	-	0.02	-
Net Debt / Equity Ratio	-0.06	-0.04	-0.47	-0.44	-0.37	-0.32
Net Debt / EBITDA Ratio	-0.60	-4.12	-45.61	1401.47	7.08	0.67
Net Debt / FCF Ratio	-	0.05	10.16	1.31	13.42	-1.49
Asset Turnover	-	1.78	0.62	0.24	0.97	0.82
Inventory Turnover	-	50.81	10.24	2.12	10.66	11.36
Quick Ratio	-	1.96	373.65	60.39	4.98	1.92
Current Ratio	-	2.79	407.44	68.83	6.38	3.37
Return on Equity (ROE)	-	0.68%	0.14%	-0.81%	-26.95%	-40.70%
Return on Assets (ROA)	-	0.46%	0.33%	-0.46%	-3.29%	-19.64%
Return on Invested Capital (ROIC)	7.48%	0.84%	0.48%	-1.32%	-9.60%	-46.53%
Return on Capital Employed (ROCE)	-	0.70%	0.50%	-0.80%	-6.20%	-49.50%
Earnings Yield	1.64%	0.32%	0.07%	-0.82%	-28.15%	-68.74%
FCF Yield	-	-52.09%	-2.47%	-33.05%	-2.94%	28.55%
Buyback Yield / Dilution	-63.39%	9.80%	-28.54%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.